Researchers have been excited about Retatrutide , a novel dual compound showing promising data in clinical trials for body reduction . It acts by targeting both hormones : GLP-1 and GIP, which , when https://nevefdmk462223.blogolenta.com/37806659/this-new-hope-for-body-loss